Amin Dipti
Transaction: 07/01/2026
BUY
Change
+125,000
Price
$1.30
Filing
07/02/2026
Type
BUY
Lineage Cell Therapeutics, Inc.
LCTX • Biotechnology
$1.08
▼ -0.02 (-1.82%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$282.39M
Growth
2.8%
Cash Flow
1/5
Trend
Volatile
Evidence
Positive revenue growth · 27.8%Manageable debt level · 0.05Healthy liquidity · 5.2Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 13, 2026, 12:48 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$1.08
Change-1.82%
Shares Out261.47M
Market Cap$282.39M
Enterprise Value$233.86M
52W Range0.97 - 2.09
Beta1.55
P/E-8.75
P/S21.58
P/B4.72
P/FCF-11.80
EV/Sales17.88
Price$1.08
Change-1.82%
Shares Out261.47M
Market Cap$282.39M
Enterprise Value$233.86M
52W Range0.97 - 2.09
Beta1.55
P/E-8.75
P/S21.58
P/B4.72
P/FCF-11.80
EV/Sales17.88
EV/EBITDA-5.60
EV/FCF-9.77
Earnings Yield-11.42%
FCF Yield-8.48%
Dividend Yield0.00%
Gross Margin94.19%
Oper. Margin-149.62%
Profit Margin-4.36%
Debt/Eq0.05
Current Ratio5.20
Quick Ratio5.20
Revenue 5Y2.77%
Volume679.59K
Avg Volume1.36M
EPS Surprise-0.01
Investment DNA
How strong this company looks for long-term investors
45
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
26/100
Why this score▼
Positive revenue growth · 27.8%Manageable debt level · 0.05Healthy liquidity · 5.2Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 5 analyst votes · 2026-09-05
100/100
Bullish
Bullish
5
Hold
0
Bearish
0
Insider Transactions
Recent executive and insider activity
Russell Angus C.
Transaction: 07/01/2026
BUY
Change
+125,000
Price
$1.30
Filing
07/02/2026
Type
BUY
ANDREWS DEBORAH J
Transaction: 07/01/2026
BUY
Change
+125,000
Price
$1.30
Filing
07/02/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Amin Dipti | BUY | +125,000 | $1.30 | 07/01/2026 | 07/02/2026 |
| Russell Angus C. | BUY | +125,000 | $1.30 | 07/01/2026 | 07/02/2026 |
| ANDREWS DEBORAH J | BUY | +125,000 | $1.30 | 07/01/2026 | 07/02/2026 |
| Mulroy Michael H. | BUY | +125,000 | $1.30 | 07/01/2026 | 07/02/2026 |
| Jayasuriya Anula | BUY | +125,000 | $1.30 | 07/01/2026 | 07/02/2026 |
| Bradsher Neal C | BUY | +125,000 | $1.30 | 07/01/2026 | 07/02/2026 |
| Culley Brian M | BUY | +15,000 | $1.63 | 03/12/2026 | 03/12/2026 |
| Samuel George A. III | BUY | +900,000 | $1.84 | 03/05/2026 | 03/06/2026 |
| Howe Jill Ann | BUY | +1,050,000 | $1.84 | 03/05/2026 | 03/06/2026 |
| Culley Brian M | BUY | +3,250,000 | $1.84 | 03/05/2026 | 03/06/2026 |
| Samuel George A. III | SELL | -6,075 | Not reported | 02/11/2026 | 02/13/2026 |
| Samuel George A. III | SELL | -2,502 | $1.80 | 02/11/2026 | 02/13/2026 |
| Culley Brian M | SELL | -31,250 | Not reported | 02/11/2026 | 02/13/2026 |
| Culley Brian M | SELL | -12,869 | $1.80 | 02/11/2026 | 02/13/2026 |
| Samuel George A. III | SELL | -65 | $1.68 | 12/19/2025 | 12/19/2025 |
| Culley Brian M | SELL | -334 | $1.68 | 12/19/2025 | 12/19/2025 |
| Bradsher Neal C | BUY | +75,000 | $0.90 | 07/01/2025 | 07/03/2025 |
| ANDREWS DEBORAH J | BUY | +75,000 | $0.90 | 07/01/2025 | 07/02/2025 |
| Mulroy Michael H. | BUY | +75,000 | $0.90 | 07/01/2025 | 07/02/2025 |
| Russell Angus C. | BUY | +75,000 | $0.90 | 07/01/2025 | 07/02/2025 |